Senior insider sale
EVP, Chief Commercial Officer at RIGEL PHARMACEUTICALS INC — senior position signals high conviction
$83.8K
3.92K shares
What this filing means
SANTOS DAVID A plans to sell 3.92K shares of RIGEL PHARMACEUTICALS INC valued at approximately $83.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/5/2025ACC: 0001959173-25-000721
Officer· EVP, Chief Commercial Officer
Since Aug 2020
3.92K
Shares to sell
$83.8K
Approx. market value
1.80K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/4/2025
1.80KTotal acquired1.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/4/2025 | Restricted Stock Vesting Compensation | 1.80K | — |
| Total | 1.80K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.13K
Market value
$44.5K
2/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.80K
Market value
$39.4K
2/5/2025
Total
Units
3.92K
Value
$83.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2025 | 2.13K | $44.5K | — | Completed |
| Planned — Approximate Date | ||||
2/5/2025 | 1.80K | $39.4K | NASDAQ | Planned |
| Total | 3.92K | $83.8K | ||